How 23andMe is Helping People Better Understand Their DNA
Market research firm Kalorama Information estimates the consumer market for genetic health testing could triple by 2022. 23andMe's Director of Product Science Shirley Wu explains how the testing company is differentiating itself in this growing market.
"We are the only direct-to-consumer genetic testing company that provides health related information," said Wu. "We believe that everyone has the right to their own DNA information. It's information about you--you should know it if you want to know it."
23andMe CEO Anne Wojcicki has been outspoken about the company's efforts to maintain a gender-equal workforce. "It's been really great to be a part of a company like that where from the beginning we had really strong female leaders who set the vision for the company," says Wu. "There's never been a question of can women hold their own."
Apple Pay is getting in on the buy now pay later boom with a feature allowing users to split purchases into four separate payments over six weeks at no additional cost or interest.
San Francisco-based technology startup Illumix just closed a $18 million Series A round of funding, and in a rare move for the Shark Tank star, Mark Cuban contributed.
Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report.
A Minnesota utility began shutting down a nuclear power plant near Minneapolis on Friday after discovering water containing a low level of radioactive material was leaking from a pipe for the second time. While the utility and health officials say it is not dangerous, the issue has prompted concerns among nearby residents and raised questions about aging pipelines.
